Paragangliomas (PGLs) are rare tumors derived from neural crest cells with heterogeneous morphology and clinical behavior. Some PGLs exhibit pathologic changes described as cystic or necrotic degeneration. The prevalence of these alterations and their clinical significance have been incompletely characterized. The analyzed study aimed to assess how cystic and necrotic alterations relate to clinical presentation, tumor burden, metastasis, and cardiovascular complications.
The authors performed a retrospective single‑center study covering 2011–2021 that included 103 patients with histologically confirmed PGLs. Tumors were evaluated for cystic and necrotic alterations based on available imaging, original pathology reports, and pathological re‑evaluation. In addition to the single‑center series, the work included a meta‑analysis incorporating a total of 235 patients with PGLs to compare outcomes between necrotic and cystic tumors.
Cystic alterations—encompassing microscopic cystic spaces, macroscopic cysts, and so‑called pseudocystic changes—were observed in 61.8% of PGLs in the single‑center cohort. Despite this high prevalence, the presence of cystic degeneration did not measurably affect the clinical presentation of affected patients in that cohort. The abstract reports no association between cystic changes and increased symptoms, tumor volume, or metastatic risk in the studied population.
Necrotic alterations were far less common in the single‑center series, identified in 3.9% of tumors. Compared with PGLs without cystic or necrotic changes, necrotic PGLs demonstrated several adverse associations in the reported cohort:
These findings indicate that necrosis within PGLs correlated with both greater tumor burden and more aggressive clinical behavior in this series.
In the single‑center cohort, both cystic and necrotic lesions were more frequently observed in adrenal PGLs than in extra‑adrenal PGLs. The abstract does not provide detailed counts or percentages by site beyond this comparative statement.
The meta‑analysis component pooled data on 235 patients with PGLs and confirmed key associations observed in the single‑center series:
These pooled data support an association between necrosis and both metastatic potential and cardiovascular risk across reported series.
The combined single‑center observations and meta‑analytic results suggest that pathological alterations—particularly tumor necrosis—may have prognostic and management relevance in PGLs. Specific implications highlighted by the authors include:
The abstract indicates these features should be incorporated into preoperative management and follow‑up planning, but does not enumerate precise protocol changes or monitoring intervals.
The source material is an abstract and omits several granular details. Reported limitations or absent information include:
Because these details were not reported in the source abstract, they could not be further summarized here.
In this retrospective single‑center series of 103 PGL patients and a meta‑analysis of 235 patients, necrotic paragangliomas were uncommon but associated with substantially higher metastatic rates, larger tumor volumes, and more symptomatic presentations compared with cystic or non‑altered tumors. The pooled evidence also linked necrosis to an increased frequency of cardiovascular complications. The authors conclude that pathological alterations—especially necrosis—should be considered when planning preoperative management and follow‑up for patients with PGLs. The abstract does not provide additional methodological or follow‑up protocol details beyond these conclusions.